In a cohort study of 734 IBD patients treated with anti-TNF therapy, compared with 666 patients receiving other treatments, age at the initiation of anti-TNF therapy was the sole independent predictor of mortality 20. This evidence concerns the gene TNF and inflammatory bowel disease.